GH, directly or indirectly via IGF-1, has been shown to increase expression of the ABCB, ABCC, and ABCG subfamilies of ABC transporters in breast cancer [15], melanoma [20,33], ovarian cancer [133,134], colorectal cancer [135], and leukemia [136]. This evidence concerns the gene GH1 and ovarian carcinoma.